Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$11.60 +0.38 (+3.39%)
At close: Nov 11, 2026 · 4:00 PM EST

Enanta Pharmaceuticals (ENTA) Change in Accrued Expenses (2012 - 2026)

Updated

Enanta Pharmaceuticals' Change in Accrued Expenses came in at $3.32 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 31.7% from $2.52 million a year earlier.

Analysis

Enanta Pharmaceuticals (ENTA) Change in Accrued Expenses (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Enanta Pharmaceuticals reported Change in Accrued Expenses of -$150,000; for FY2025 (ended Sep 30, 2025), it was $58,000.

  • Going back by fiscal year, Change in Accrued Expenses was -$5.65 million in FY2024, -$2.56 million in FY2023, -$1.48 million in FY2022 and $8.35 million in FY2021.
  • The fiscal Q3 2026 figure represents the highest quarterly Change in Accrued Expenses since fiscal Q1 2022.
  • Year-over-year, Change in Accrued Expenses increased in three of the last four quarters, with growth averaging 134.3%.
  • The fastest year-over-year change in Change in Accrued Expenses over five years came in fiscal Q4 2021 (growth of 723.8%), and the weakest in fiscal Q4 2022 (a decline of 62.0%).
  • Business Quant data shows ENTA's Change in Accrued Expenses at -$716,000 (Q2 2026), -$5.18 million (Q1 2026) and $2.42 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Enanta Pharmaceuticals 326.73 Mn -401.27 Mn - 3.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.32 Mn
Mar 31, 2026 -716,000.00
Dec 31, 2025 -5.18 Mn
Sep 30, 2025 2.42 Mn
Jun 30, 2025 2.52 Mn
Mar 31, 2025 -1.97 Mn
Dec 31, 2024 -2.91 Mn
Sep 30, 2024 401,000.00
Jun 30, 2024 1.66 Mn
Mar 31, 2024 -973,000.00
Dec 31, 2023 -6.74 Mn
Sep 30, 2023 792,000.00
Jun 30, 2023 2.70 Mn
Mar 31, 2023 547,000.00
Dec 31, 2022 -6.60 Mn
Sep 30, 2022 1.78 Mn
Jun 30, 2022 -2.45 Mn
Mar 31, 2022 -5.01 Mn
Dec 31, 2021 4.21 Mn
Sep 30, 2021 4.68 Mn
API Access

Enanta Pharmaceuticals Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ENTA&period=max&api_key=YOUR_API_KEY